This inventor holds 2 USPTO granted patents. Top assignee: Glycolysis Biomed Co., Ltd.. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Innovations by Chun-Tsung Lo in Glucose Metabolism Disorders
Introduction
Chun-Tsung Lo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the area of glucose metabolism disorders. With a total of 2 patents, his work focuses on innovative methods for treatment and prevention.
Latest Patents
Chun-Tsung Lo's latest patents include a method involving beta-lactam compounds or salts thereof for long-acting prevention or treatment of glucose metabolism disorders. This method provides a long-acting effect that lasts more than two days, even after the medication has been stopped. The administration of these compounds offers a promising approach for individuals in need of effective management of glucose metabolism disorders.
Career Highlights
Chun-Tsung Lo is currently associated with Glycolysis Biomed Co., Ltd., where he continues to advance his research and innovations. His work is pivotal in developing new therapeutic strategies that can significantly improve patient outcomes.
Collaborations
Chun-Tsung Lo collaborates with esteemed colleagues such as Yen-Chun Huang and Feng-Ling Lee. Their combined expertise enhances the research efforts at Glycolysis Biomed Co., Ltd.
Conclusion
Chun-Tsung Lo's contributions to the field of glucose metabolism disorders through his innovative patents highlight his role as a leading inventor in biomedical research. His work promises to pave the way for more effective treatments in the future.